Related Experiment Video

Updated: Jun 28, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K

Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment

Mengxin Wang1,2, Stephen Vulcano3, Changlu Xu4

  • 1Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.

Journal of Pharmaceutical Analysis
|April 15, 2024
PubMed

Insights

Ribosomopathies, disorders of ribosome function, increase cancer susceptibility. This review explores ribosomopathy genes in cancer, aiming to identify new diagnostic biomarkers and therapeutic targets for malignancies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Ribosomopathies result from impaired ribosome biogenesis and function.
  • These genetic disorders are linked to increased cancer susceptibility.
  • Ribosomopathy genes are implicated in cancer development and progression.

Purpose of the Study:

  • To review recent advances in ribosomopathy gene research in human cancers.
  • To explore the potential roles of understudied ribosomopathy genes in cancer development.
  • To establish a framework connecting ribosomopathy genes to cancer for biomarker and therapeutic development.

Main Methods:

  • Literature review of ribosomopathy genes and their association with various cancers.
  • Analysis of existing data to identify novel roles for specific ribosomopathy genes in oncogenesis.
  • Bioinformatic and statistical analyses to establish correlations.

Main Results:

  • Established a strong correlation between ribosome biogenesis defects and malignancy.
  • Identified several ribosomopathy genes with significant roles in cancer development.
  • Highlighted potential novel roles for under-researched ribosomopathy genes in oncogenesis.

Conclusions:

  • Ribosomopathy genes represent a promising area for cancer biomarker discovery.
  • Targeting ribosomopathy pathways offers potential therapeutic strategies for cancer treatment.
  • Further research into the specific roles of these genes can advance precision oncology.
Keywords:
Cancer treatment targetPharmaceutical targetRibosome biogenesisRibosomopathy gene

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.8K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
12.3K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.5K